Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Benny Holmberg"'
Autor:
E Olausson, Bernd Stegmayr, D Welin, Henrik Hadimeri, B Ingman, A M Wikdahl, K Lindberger, Benny Holmberg, E Dimeny, M Brännström, B Granroth, G Johansson, V Crougneau, B Persson, KC Gröntoft, A Ekspong, B Bucht, B Isaksson, Lennart Lundberg, L Mikaelsson
Publikováno v:
Scandinavian Journal of Urology and Nephrology. 39:503-510
To investigate the efficacy and safety of a daily dose of 10 mg of atorvastatin in patients with chronic kidney disease (CKD) stages 4 and 5 and a glomerular filtration rate of30 ml/min.This was an open, prospective, randomized study. A total of 143
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd9b531862c07291939dc550713af4b0
https://doi.org/10.1080/00365590510031255
https://doi.org/10.1080/00365590510031255
Autor:
B Isaksson, E Dimeny, Henrik Hadimeri, L Mikaelsson, A-M Wikdahl, Marie Eriksson, E Olausson, M Brännström, Bernd Stegmayr, B Ingman, K Lindberger, A Ekspong, Britt C. Persson, Benny Holmberg, G Johansson, B Granroth, Lennart Lundberg, Crougneau, KC Gröntoft, Hans Stenlund, S Bucht
Publikováno v:
Scandinavian Journal of Urology and Nephrology. 39:489-497
There have been no endpoint studies with statins for patients with severe renal failure. The purpose of this prospective, open, randomized, controlled study was to investigate whether atorvastatin (10 mg/day) would alter cardiovascular endpoints and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff4c8e29d4e554a762138715e9e275b3
https://doi.org/10.1080/00365590500329304
https://doi.org/10.1080/00365590500329304
Autor:
Benny Holmberg, Bernd Stegmayr
Publikováno v:
Hemodialysis international. International Symposium on Home Hemodialysis. 13(1)
The risk of death is increased for hemodialysis (HD) patients compared with age-matched healthy subjects, the main reason for this being cardiovascular conditions. This prospective study investigated whether the burden of interdialytic weight gain (I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74ee385d45c05e134881c6b6f7d4d1d8
https://pubmed.ncbi.nlm.nih.gov/19210274
https://pubmed.ncbi.nlm.nih.gov/19210274
Autor:
Bernd Stegmayr, L Mikaelsson, Monica Mörtzell, A Ekspong, S Bucht, K Lindberger, A M Wikdahl, B Granroth, G Johansson, B Ingman, M Brännström, B Isaksson, Lennart Lundberg, Henrik Hadimeri, E Olausson, KC Gröntoft, L. Svensson, Britt C. Persson, Benny Holmberg, E Dimeny, Ola Lundström
Publikováno v:
Europe PubMed Central
Background and aim: There had been no randomized end-point studies with statins for patients with severe renal failure. The purpose of this prospective, open, randomized, controlled study was to investigate whether atorvastatin (10 mg/day) would alte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42a27654e56aec807616b34805111b25
http://europepmc.org/abstract/med/16874672
http://europepmc.org/abstract/med/16874672
